Roivant Sciences Ltd. Annual Reports (10-K)
Every annual report 10-K going back 6 years. Put here in one place for you.
Page 1 of 6
2026-2021
| Currency in USD | 2026 |
|---|---|
| Operating Income | -515.07 Million |
| Income Before Tax | -264.58 Million |
| Income Tax Expense | 133.33 Million |
| Net Income | -299.77 Million |
| Eps | -0.43 |
| Epsdiluted | -0.54 |
| Weighted Average Shs Out | 693.86 Million |
| Weighted Average Shs Out Dil | 693.86 Million |
| Research And Development Expenses | 681.81 Million |
| Selling General And Administrative Expenses | N/A |
| Depreciation And Amortization | 3.35 Million |
| Interest Expense | N/A |
| Interest Income | 178.11 Million |
| Net Interest Income | 178.11 Million |
| Premiums Earned | N/A |
| Policyholder Benefits | N/A |
| Gross Profit | 6.97 Million |
| Ebitda | -511.72 Million |
| Source | edgar |
| Ebit | -1.29 Billion |